Clinical Trial Update: Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating insulin-like growth factor-1 for amyotrophic lateral sclerosis completed, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Insulin-like Growth Factor-1 (insulin-like growth factor-1)

Snippet

Sponsor: Mayo Clinic | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2013-02-15